EU Extends Inspection Of Teva-Barr Deal

Law360, New York (December 2, 2008, 12:00 AM EST) -- The European Union’s antitrust watchdog pushed back the deadline for its review of Teva Pharmaceutical Industries Ltd.'s proposed multibillion-dollar takeover of generic-drug rival Barr Pharmaceuticals Inc. on Tuesday.

The European Commission extended its inspection of the proposed merger from Dec. 8 to Dec. 22 as it takes a look at remedies to mitigate potential risks to competition, according to the EC’s daily list of mergers under review.

In a first-phase merger inquiry, there is an automatic 10-working-day extension of the deadline if the parties offer remedies,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.